| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |